Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain

被引:97
作者
Hai, J
Li, ST
Lin, Q
Pan, QG
Gao, F
Ding, MX
机构
[1] Tongji Univ, Tongji Hosp, Dept Neurosurg, Shanghai 200065, Peoples R China
[2] Shanghai Med Univ 2, Dept Chem, Shanghai, Peoples R China
[3] Shanghai Med Univ 2, Dept Cytobiol, Shanghai, Peoples R China
[4] Shanghai Med Univ 2, Peoples Hosp 9, Dept Neurosurg, Shanghai, Peoples R China
关键词
angiogenesis; animal model; carotid artery-jugular vein fistula; cerebral arteriovenous malformations; vascular endothelial growth factor;
D O I
10.1227/01.NEU.0000083594.10117.7A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: In a rat model, we studied the time courses of vascular endothelial growth factor (VEGF) expression and angiogenesis induced by chronic cerebral hypoperfusion in the brain, and we investigated the histological bases of normal-perfusion pressure breakthrough. METHODS: Twenty-one Sprague-Dawley rats were randomly divided into a control group ( n = 3) and a model group assessed at various time points after the creation of a carotid artery-jugular vein fistula (12 h, n = 3; 24 h, n = 3; 72 h, n = 3; 7 d, n = 3; 21 d, n = 3; 90 d, n = 3). The time courses of the expression of VEGF messenger ribonucleic acid (mRNA) and protein in rat brain were analyzed with semiquantitative reverse transcriptase-polymerase chain reaction and Western blot assays, respectively. Immunohistochemical techniques were used to evaluate VEGF protein localization with rabbit polyclonal anti-rat VEGF, VEGF receptor (VEGFR) expression with rabbit polyclonal antibodies to VEGFR-1 and -2, microvascular density with mouse monoclonal anti-rat CD31, and astrocytic reactivity with polyclonal anti-glial fibrillary acidic protein, in cerebral cortical tissue of the right middle cerebral artery territory. RESULTS: Three alternative splicing forms, i.e., VEGF(188), VEGF(164), and VEGF(120), were observed in cerebral coritcal tissue of the right middle cerebral artery territory in semiquantitative reverse transcriptase-polymerase chain reaction analyses. VEGF(164) mRNA was the predominant isoform expressed in rat brain. VEGF(188) mRNA and VEGF(120) mRNA were also detected but at very low levels (not statistically significant). Low levels of VEGF(164) mRNA were observed in the control brains. However, VEGF(164) mRNA levels were significantly increased in the model brains at 24 hours postoperatively, peaked by 7 days, decreased by 21 days, and returned to basal levels by 90 days after fistula formation. VEGF protein expression, as measured in Western blot assays, was also increased in rat brains in the model group from 24 hours to 21 days postoperatively but returned to control levels by 90 days after fistula formation. VEGF immunohistochemical analyses indicated that this increased expression was mostly associated with endothelial cells. Consistent with the VEGF protein expression findings, up-regulation of VEGFR-1 but not VEGFR-2 expression on endothelial cells in the model brains was observed. Microvascular density in the rat brains began to increase significantly 7 days after fistula formation in the model group, as assessed immunohistochemically, and the increase was maintained for 90 days. Although no prominent astrocytic reactivity was observed in the rat brains throughout the experiments, there was an absence of astrocytic foot processes surrounding some cerebral capillaries 90 days after fistula formation in the model group. CONCLUSION: These results demonstrated that chronic cerebral hypoperfusion could induced sustained up-regulation of VEGF mRNA and protein expression in rat brain, which was correlated with angiogenesis. An absence of corresponding astrocytic reactivity during angiogenesis may be an important factor accounting for structural deficits of the blood-brain barrier and the occurrence of normal-perfusion pressure breakthrough.
引用
收藏
页码:963 / 970
页数:8
相关论文
共 40 条
  • [1] OCCLUSIVE HYPEREMIA - A THEORY FOR THE HEMODYNAMIC COMPLICATIONS FOLLOWING RESECTION OF INTRACEREBRAL ARTERIOVENOUS-MALFORMATIONS
    ALRODHAN, NRF
    SUNDT, TM
    PIEPGRAS, DG
    NICHOLS, DA
    RUFENACHT, D
    STEVENS, LN
    [J]. JOURNAL OF NEUROSURGERY, 1993, 78 (02) : 167 - 175
  • [2] DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VASCULAR-PERMEABILITY FACTOR) FORMS IN RAT-TISSUES
    BACIC, M
    EDWARDS, NA
    MERRILL, MJ
    [J]. GROWTH FACTORS, 1995, 12 (01) : 11 - 15
  • [3] INTRACRANIAL VENOUS HYPERTENSION AND THE EFFECTS OF VENOUS OUTFLOW OBSTRUCTION IN A RAT MODEL OF ARTERIOVENOUS-FISTULA
    BEDERSON, JB
    WIESTLER, OD
    BRUSTLE, O
    ROTH, P
    FRICK, R
    YASARGIL, MG
    [J]. NEUROSURGERY, 1991, 29 (03) : 341 - 350
  • [4] Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat
    Cobbs, CS
    Chen, J
    Greenberg, DA
    Graham, SH
    [J]. NEUROSCIENCE LETTERS, 1998, 249 (2-3) : 79 - 82
  • [5] AMINO-ACID AND CDNA SEQUENCES OF A VASCULAR ENDOTHELIAL-CELL MITOGEN THAT IS HOMOLOGOUS TO PLATELET-DERIVED GROWTH-FACTOR
    CONN, G
    BAYNE, ML
    SODERMAN, DD
    KWOK, PW
    SULLIVAN, KA
    PALISI, TM
    HOPE, DA
    THOMAS, KA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) : 2628 - 2632
  • [6] A PATHOLOGICAL CORRELATE OF THE STEAL PHENOMENON IN A PATIENT WITH CEREBRAL ARTERIOVENOUS MALFORMATION
    COSTANTINO, A
    VINTERS, HV
    [J]. STROKE, 1986, 17 (01) : 103 - 106
  • [7] DVORAK HF, 1995, AM J PATHOL, V146, P1029
  • [8] The biology of vascular endothelial growth factor
    Ferrara, N
    DavisSmyth, T
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
  • [9] REGULATION OF ANGIOGENIC GROWTH-FACTOR EXPRESSION BY HYPOXIA, TRANSITION-METALS, AND CHELATING-AGENTS
    GLEADLE, JM
    EBERT, BL
    FIRTH, JD
    RATCLIFFE, PJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 268 (06): : C1362 - C1368
  • [10] Guo Y, 1997, J NEUROSCI RES, V49, P89, DOI 10.1002/(SICI)1097-4547(19970701)49:1<89::AID-JNR10>3.0.CO